MECHANISM OF INHIBITION OF HIV-1 REVERSE-TRANSCRIPTASE BY NONNUCLEOSIDE INHIBITORS

被引:416
作者
ESNOUF, R
REN, JS
ROSS, C
JONES, Y
STAMMERS, D
STUART, D
机构
[1] OXFORD CTR MOLEC SCI, OXFORD OX1 3QT, ENGLAND
[2] WELLCOME RES LABS, STRUCT BIOL GRP, BECKENHAM BR3 3BS, KENT, ENGLAND
来源
NATURE STRUCTURAL BIOLOGY | 1995年 / 2卷 / 04期
关键词
D O I
10.1038/nsb0495-303
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The structure of unliganded HIV-1 reverse transcriptase has been determined at 2.35 Angstrom resolution and refined to an R-factor of 0.219 (for all data) with good stereochemistry. The unliganded structure was produced by soaking out a weak binding non-nucleoside inhibitor, HEPT, from pregrown crystals. Comparison with the structures of four different RT and non-nucleoside inhibitor complexes reveals that only minor domain rearrangements occur, but there is a significant repositioning of a three-stranded beta-sheet in the p66 subunit (containing the catalytic aspartic acid residues 110, 185 and 186) with respect to the rest of the polymerase site. This suggests that NNIs inhibit RT by locking the polymerase active site in an inactive conformation, reminiscent of the conformation observed in the inactive p51 subunit.
引用
收藏
页码:303 / 308
页数:6
相关论文
共 25 条
[1]   HIGHLY SPECIFIC-INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 BY A NOVEL 6-SUBSTITUTED ACYCLOURIDINE DERIVATIVE [J].
BABA, M ;
TANAKA, H ;
DECLERCQ, E ;
PAUWELS, R ;
BALZARINI, J ;
SCHOLS, D ;
NAKASHIMA, H ;
PERNO, CF ;
WALKER, RT ;
MIYASAKA, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 165 (03) :1375-1381
[2]   INTERACTION OF THE REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH DNA [J].
BAKHANASHVILI, M ;
HIZI, A .
BIOCHEMISTRY, 1994, 33 (40) :12222-12228
[3]   SLOW-COOLING PROTOCOLS FOR CRYSTALLOGRAPHIC REFINEMENT BY SIMULATED ANNEALING [J].
BRUNGER, AT ;
KRUKOWSKI, A ;
ERICKSON, JW .
ACTA CRYSTALLOGRAPHICA SECTION A, 1990, 46 :585-593
[4]   EXTENSION OF MOLECULAR REPLACEMENT - A NEW SEARCH STRATEGY BASED ON PATTERSON CORRELATION REFINEMENT [J].
BRUNGER, AT .
ACTA CRYSTALLOGRAPHICA SECTION A, 1990, 46 :46-57
[5]  
BRUNGER AT, 1992, E COMMUNICATION
[6]   AN ANTIVIRAL TARGET ON REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVEALED BY TETRAHYDROIMIDAZO[4,5,1-JK][1,4]BENZODIAZEPIN-2(1H)-ONE AND TETRAHYDROIMIDAZO-[4,5,1-JK][1,4]BENZODIAZEPIN-2(1H)-ONE-THIONE DERIVATIVES [J].
DEBYSER, Z ;
PAUWELS, R ;
ANDRIES, K ;
DESMYTER, J ;
KUKLA, M ;
JANSSEN, PAJ ;
DECLERCQ, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (04) :1451-1455
[7]  
DEBYSER Z, 1992, MOL PHARMACOL, V41, P203
[8]   HIV-1-SPECIFIC RT INHIBITORS - HIGHLY SELECTIVE INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 THAT ARE SPECIFICALLY TARGETED AT THE VIRAL REVERSE-TRANSCRIPTASE [J].
DECLERCQ, E .
MEDICINAL RESEARCH REVIEWS, 1993, 13 (03) :229-258
[9]   KINETICS OF INTERACTION OF HIV REVERSE-TRANSCRIPTASE WITH PRIMER TEMPLATE [J].
DIVITA, G ;
MULLER, B ;
IMMENDORFER, U ;
GAUTEL, M ;
RITTINGER, K ;
RESTLE, T ;
GOODY, RS .
BIOCHEMISTRY, 1993, 32 (31) :7966-7971
[10]  
JONES TA, 1985, METHOD ENZYMOL, V115, P157